Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neural Therapy Effect and Bilateral Tubal Ligation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03891537
Recruitment Status : Completed
First Posted : March 27, 2019
Last Update Posted : March 28, 2019
Sponsor:
Information provided by (Responsible Party):
Pınar Kadirogulları, Kanuni Sultan Suleyman Training and Research Hospital

Brief Summary:

The aim of this study is to evaluate the effect of nebulisation in patients with bilateral tubal ligation in the first postoperative year, the amount of dysmenorrhea, dyspareunia and menstrual bleeding, recurrent vaginitis and cystitis.

A retrospective analysis of bilateral tubal ligation with optional modified Pomeroy technique in the family planning unit and evaluation of the results of patients who underwent Neural Therapy during and postoperatively will be evaluated.


Condition or disease
Tubal Obstruction Dysmenorrhea

Layout table for study information
Study Type : Observational
Actual Enrollment : 113 participants
Observational Model: Case-Control
Time Perspective: Retrospective
Official Title: Evaluation Of The Neural Therapy Effect On Long Term Postoperative Discomforts İn Patients Who Undergo Bilateral Tubal Ligation
Actual Study Start Date : January 1, 2016
Actual Primary Completion Date : January 1, 2018
Actual Study Completion Date : January 1, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Period Pain




Primary Outcome Measures :
  1. postoperative dysmenorrhea [ Time Frame: 1st year postoperative ]

    Postoperative dysmenorrhea in the first postoperative year was evaluated by viscous pain scale (VAS) in patients who underwent bilateral tubal ligation with the modified Pomeroy technique. There is no pain at zero points according to visuel pain scale;Ten points are very severe - unbearable pain.

    patients will score between one to ten pains.


  2. postoperative dyspareunia [ Time Frame: 1st year postoperative ]

    Postoperative dyspareunia in the first postoperative year was evaluated by viscous pain scale (VAS) in patients who underwent bilateral tubal ligation with the modified Pomeroy technique. There is no pain at zero points according to visuel pain scale;Ten points are very severe - unbearable pain.

    patients will score between one to ten pains.




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients who had bilateral tubal ligation with modified Pomeroy technique and had complaints such as dysmenorrhea dyspareunia in the first postoperative year
Criteria

Inclusion Criteria:

  • patients who underwent bilateral tubal ligation with modified Pomeroy technique,
  • Patients with dysmenore, dyspareunia and menstrual bleeding,

Exclusion Criteria:

  • postoperative asymptomatic
  • Additional treatments for pain and complaints

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03891537


Locations
Layout table for location information
Turkey
Kanuni Sultan Süleyman Training and Research Hospital
Istanbul, Turkey, 33404
Sponsors and Collaborators
Kanuni Sultan Suleyman Training and Research Hospital
Layout table for additonal information
Responsible Party: Pınar Kadirogulları, principal investigator, M.D, Department of Obstetrics and Gynecology, Kanuni Sultan Suleyman Training and Research Hospital
ClinicalTrials.gov Identifier: NCT03891537    
Other Study ID Numbers: 2018.10.36
First Posted: March 27, 2019    Key Record Dates
Last Update Posted: March 28, 2019
Last Verified: March 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Pınar Kadirogulları, Kanuni Sultan Suleyman Training and Research Hospital:
Bilateral Tubal Ligation
Postoperative Discomforts
Additional relevant MeSH terms:
Layout table for MeSH terms
Fallopian Tube Diseases
Dysmenorrhea
Menstruation Disturbances
Pathologic Processes
Pelvic Pain
Pain
Neurologic Manifestations
Adnexal Diseases